FDA Inspection 1100242 — Novocure Ltd
The FDA completed an inspection of Novocure Ltd on August 8, 2019 in Haifa. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 8, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Haifa (Israel)